Navigation Links
Survival rates increase with chemotherapy alone in patients with limited-stage Hodgkin's lymphoma
Date:12/12/2011

New research led by the NCIC Clinical Trials Group (CTG) at Queen's University has proven patients with limited stage Hodgkin's lymphoma have a better chance of long-term survival if they undergo a standard chemotherapy regimen as opposed to radiation-based treatment.

"These results will influence current treatment practices and lead to more patients being treated with chemotherapy alone," says Dr. Ralph Meyer, professor of oncology at Queen's and director of the NCIC CTG. "This trial exemplifies the importance of academic groups conducting trials that assess long-term patient outcomes."

Previously, a patient diagnosed with Stage 1A or Stage 2A Hodgkin's lymphoma was treated with chemotherapy and extensive radiation. This combination often results in long term-complications from radiation exposure including heart conditions or subsequent cancers. This study proves chemotherapy alone increases survival rates in the early stages of the disease. The trial began in 1994 and has recently undergone its final analysis.

Today's practices incorporate reduced amounts of radiation as compared with those tested in the trial, but the results demonstrate chemotherapy alone will be a preferred option for many patients.

The study was made possible through NCIC CTG's grant funding from the Canadian Cancer Society Research Institute. The NCIC CTG led this trial in collaboration with the US-based Eastern Cooperative Oncology Group (ECOG). Both NCIC CTG and ECOG received grant funding support from the US National Cancer Institute.

The results were published on-line by the New England Journal of Medicine. Dr. Meyer presented the results December 12 at the American Society of Hematology conference in San Diego.


'/>"/>

Contact: Anne Craig
anne.craig@queensu.ca
613-533-2877
Queen's University
Source:Eurekalert

Page: 1

Related medicine news :

1. Circulating tumor cells not linked to survival in newly diagnosed inflammatory breast cancer
2. Avastin Boosted Survival for Type of Aggressive Breast Cancer: Study
3. Exemestane plus everolimus increased progression-free survival
4. Immediate bisphosphonate use with endocrine therapy reduced recurrence and increased survival in postmenopausal early breast cancer
5. Changing order drugs are taken boosts breast cancer survival
6. Steroids May Boost Survival for Very Preemie Babies
7. Survival difference are not black and white
8. University of Kentucky researchers awarded CDC grant to study cancer survival in Appalachia
9. Everolimus prolongs progression-free survival for patients with neuroendocrine tumors
10. Fatty Liver Disease Doesnt Affect Survival, Study Finds
11. Surgery May Boost Survival With Dangerous Heart Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: